网站大量收购独家精品文档,联系QQ:2885784924

Mutagenicity of anticancer drugs and Clofarabine Study hemolytic.doc

Mutagenicity of anticancer drugs and Clofarabine Study hemolytic.doc

  1. 1、本文档共16页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Mutagenicity of anticancer drugs and Clofarabine Study hemolytic

 PAGE \* MERGEFORMAT 16 Mutagenicity of anticancer drugs and Clofarabine Study hemolytic Of: Li Xinhua, Sun Xin Xin, Cui Fei, Xiao-Yan Wang, Yuan side [Abstract] Objective Clofarabine (referred to as CLO) on bone marrow red blood cells and germ cells of male mice with or without mutagenic and teratogenic effects, and whether the dissolution of the peripheral red blood cells. Methods micronucleus test on bone marrow RBC CLO mutagenicity, the use of sperm abnormality test in mice germ cells CLO teratogenic effects, the use of human red blood cells hemolytic CLO test. Results The micronucleus test, CLO test group and the positive control group between the two groups was not significant (Pgt; 0.01), with the negative control group difference was significant (P lt;0.05). sperm abnormality test, CLO test group and positive control group showed no significant (Pgt; 0.05), but with the negative control group There was a significant difference between (P lt;0.01). CLO in vitro dissolution of human red blood cells not the time. Conclusion The test, CLO with other anticancer drugs such as oligonucleotides, can lead to strong cell proliferation in vivo mutations, and the distortion of germ cells; on the solubility of human red blood cells were negative. [Keywords:] Clofarabine; micronucleus test; sperm aberration; hemolytic; teratogenic; mutagenic Most of the pharmacological effects of anti-leukemia drug is based on inhibition of tumor cell DNA synthesis and the role of inhibition of some of the polymerase to prevent the proliferation of tumor cells characterized. So, the World Health Organization (WHO) had announced: starting from the DNA is the key to the treatment of cancer . Clofarabine (referred to as CLO) that is the case, as a ribonucleotide reductase inhibitor, DNA synthesis in tumor cells can be terminated to the role of killing tumor cells [1], then the normal body’s reproductive cells, bone marrow erythrocytes and peripheral blood erythrocytes of wha

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档